Skip to main content

Table 1 Baseline clinical characteristics of patients

From: 18F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma

Characteristics

Level

Statistic

Gender

female

48 (49.0%)

 

male

50 (51.0%)

Age_at_diagnosis

years

60.0 (± 10.6)

LDH

U/L

222.1 (± 128.5)

Hemoglobin

g/L

95.2 (± 24.3)

Globulins

g/L

50.0 (± 27.8)

Albumin

g/L

37.0 (± 7.4)

A/G ratio

 

1.1 (± 0.7)

Creatinine

μmol/L

115.6 (± 109.3)

GFR

ml/min

77.5 (± 51.5)

Calcium

mmol/L

2.5 (± 0.4)

HCT

 

0.3 (± 0.1)

Absolute Neutrophils

10^9/L

3.5 (± 1.7)

Leukocytes

10^9/L

5.7 (± 2.2)

Red blood cells

10^9/L

3.2 (± 0.8)

B2M

mg/L

7.3 (± 6.2)

ISS_staging

I

25 (25.5%)

 

II

29 (29.6%)

 

III

44 (44.9%)

Adverse prognostic cytogenetics status

No

57 (58.2%)

 

yes

41 (41.8%)

RISS_staging

I

23 (23.5%)

 

II

46 (46.9%)

 

III

29 (29.6%)

  1. Riss Revised-International Staging System based staging, B2M β2-microglobulin, ISS International Staging System, HCT Hematocrit, A/G ratio Albumin/ Globulin (Ratio), GFR Glomerular filtration rate, LDH Lactate dehydrogenase
  2. Continuous variables are represented by the mean ± standard deviation, while categorical variables are expressed as percentages
  3. Adverse prognosis cytogenetics Status: FISH analysis confirmed del(17p), t (4;14), t (14;16), add 1q21;